Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
6892 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.720 | 1.000 | 12 | 2010 | 2016 | ||||||
GLIOMA SUSCEPTIBILITY 1
|
14 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.700 | 1.000 | 2 | 2009 | 2015 | ||||||
Angioimmunoblastic Lymphadenopathy
|
8 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||
oligodendroglioma
|
21 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||||
Well Differentiated Oligodendroglioma
|
22 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||||
Brain Neoplasms
|
204 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Brain Stem Glioma
|
45 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Colorectal Neoplasms
|
609 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
942 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Anaplastic Oligodendroglioma
|
4 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Glioblastoma
|
98 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Adult Lymphoma
|
66 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Adult Oligodendroglioma
|
19 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Anaplastic Oligodendroglioma
|
7 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinogenesis
|
355 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Childhood Anaplastic Oligodendroglioma
|
4 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Childhood Glioblastoma
|
98 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Childhood Lymphoma
|
66 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Childhood Oligodendroglioma
|
19 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Glioblastoma
|
281 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Glioblastoma Multiforme
|
186 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Lymphoma
|
91 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Spindle cell hemangioma
|
10 | 0.689 | 0.200 | 15 | 90088606 | missense variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 |